503 related articles for article (PubMed ID: 33718125)
1. A CT-Based Radiomics Approach to Predict Nivolumab Response in Advanced Non-Small-Cell Lung Cancer.
Liu C; Gong J; Yu H; Liu Q; Wang S; Wang J
Front Oncol; 2021; 11():544339. PubMed ID: 33718125
[TBL] [Abstract][Full Text] [Related]
2. A short-term follow-up CT based radiomics approach to predict response to immunotherapy in advanced non-small-cell lung cancer.
Gong J; Bao X; Wang T; Liu J; Peng W; Shi J; Wu F; Gu Y
Oncoimmunology; 2022; 11(1):2028962. PubMed ID: 35096486
[TBL] [Abstract][Full Text] [Related]
3. Enhancing brain metastasis prediction in non-small cell lung cancer: a deep learning-based segmentation and CT radiomics-based ensemble learning model.
Gong J; Wang T; Wang Z; Chu X; Hu T; Li M; Peng W; Feng F; Tong T; Gu Y
Cancer Imaging; 2024 Jan; 24(1):1. PubMed ID: 38167564
[TBL] [Abstract][Full Text] [Related]
4. Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.
Shiri I; Maleki H; Hajianfar G; Abdollahi H; Ashrafinia S; Hatt M; Zaidi H; Oveisi M; Rahmim A
Mol Imaging Biol; 2020 Aug; 22(4):1132-1148. PubMed ID: 32185618
[TBL] [Abstract][Full Text] [Related]
5. Machine learning-based radiomics strategy for prediction of cell proliferation in non-small cell lung cancer.
Gu Q; Feng Z; Liang Q; Li M; Deng J; Ma M; Wang W; Liu J; Liu P; Rong P
Eur J Radiol; 2019 Sep; 118():32-37. PubMed ID: 31439255
[TBL] [Abstract][Full Text] [Related]
6. Imaging-Based Biomarkers Predict Programmed Death-Ligand 1 and Survival Outcomes in Advanced NSCLC Treated With Nivolumab and Pembrolizumab: A Multi-Institutional Study.
Yolchuyeva S; Giacomazzi E; Tonneau M; Lamaze F; Orain M; Coulombe F; Malo J; Belkaid W; Routy B; Joubert P; Manem VSK
JTO Clin Res Rep; 2023 Dec; 4(12):100602. PubMed ID: 38124790
[TBL] [Abstract][Full Text] [Related]
7. Combination of computed tomography imaging-based radiomics and clinicopathological characteristics for predicting the clinical benefits of immune checkpoint inhibitors in lung cancer.
Yang B; Zhou L; Zhong J; Lv T; Li A; Ma L; Zhong J; Yin S; Huang L; Zhou C; Li X; Ge YQ; Tao X; Zhang L; Son Y; Lu G
Respir Res; 2021 Jun; 22(1):189. PubMed ID: 34183009
[TBL] [Abstract][Full Text] [Related]
8. Machine learning models predict overall survival and progression free survival of non-surgical esophageal cancer patients with chemoradiotherapy based on CT image radiomics signatures.
Cui Y; Li Z; Xiang M; Han D; Yin Y; Ma C
Radiat Oncol; 2022 Dec; 17(1):212. PubMed ID: 36575480
[TBL] [Abstract][Full Text] [Related]
9. Evaluating Solid Lung Adenocarcinoma Anaplastic Lymphoma Kinase Gene Rearrangement Using Noninvasive Radiomics Biomarkers.
Ma DN; Gao XY; Dan YB; Zhang AN; Wang WJ; Yang G; Zhu HZ
Onco Targets Ther; 2020; 13():6927-6935. PubMed ID: 32764984
[TBL] [Abstract][Full Text] [Related]
10. Radiomics combined with transcriptomics to predict response to immunotherapy from patients treated with PD-1/PD-L1 inhibitors for advanced NSCLC.
Bouhamama A; Leporq B; Faraz K; Foy JP; Boussageon M; Pérol M; Ortiz-Cuaran S; Ghiringhelli F; Saintigny P; Beuf O; Pilleul F
Front Radiol; 2023; 3():1168448. PubMed ID: 37492391
[TBL] [Abstract][Full Text] [Related]
11. Tumor Prognostic Prediction of Nasopharyngeal Carcinoma Using CT-Based Radiomics in Non-Chinese Patients.
Intarak S; Chongpison Y; Vimolnoch M; Oonsiri S; Kitpanit S; Prayongrat A; Kannarunimit D; Chakkabat C; Sriswasdi S; Lertbutsayanukul C; Rakvongthai Y
Front Oncol; 2022; 12():775248. PubMed ID: 35155228
[TBL] [Abstract][Full Text] [Related]
12. Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features.
Sun Z; Hu S; Ge Y; Wang J; Duan S; Song J; Hu C; Li Y
J Xray Sci Technol; 2020; 28(3):449-459. PubMed ID: 32176676
[TBL] [Abstract][Full Text] [Related]
13. Development of Radiomic-Based Model to Predict Clinical Outcomes in Non-Small Cell Lung Cancer Patients Treated with Immunotherapy.
Tankyevych O; Trousset F; Latappy C; Berraho M; Dutilh J; Tasu JP; Lamour C; Cheze Le Rest C
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497415
[TBL] [Abstract][Full Text] [Related]
14. 2D and 3D CT Radiomics Features Prognostic Performance Comparison in Non-Small Cell Lung Cancer.
Shen C; Liu Z; Guan M; Song J; Lian Y; Wang S; Tang Z; Dong D; Kong L; Wang M; Shi D; Tian J
Transl Oncol; 2017 Dec; 10(6):886-894. PubMed ID: 28930698
[TBL] [Abstract][Full Text] [Related]
15. A Machine Learning Model Based on PET/CT Radiomics and Clinical Characteristics Predicts ALK Rearrangement Status in Lung Adenocarcinoma.
Chang C; Sun X; Wang G; Yu H; Zhao W; Ge Y; Duan S; Qian X; Wang R; Lei B; Wang L; Liu L; Ruan M; Yan H; Liu C; Chen J; Xie W
Front Oncol; 2021; 11():603882. PubMed ID: 33738250
[TBL] [Abstract][Full Text] [Related]
16. An investigation of machine learning methods in delta-radiomics feature analysis.
Chang Y; Lafata K; Sun W; Wang C; Chang Z; Kirkpatrick JP; Yin FF
PLoS One; 2019; 14(12):e0226348. PubMed ID: 31834910
[TBL] [Abstract][Full Text] [Related]
17. Screening of COVID-19 based on the extracted radiomics features from chest CT images.
Rezaeijo SM; Abedi-Firouzjah R; Ghorvei M; Sarnameh S
J Xray Sci Technol; 2021; 29(2):229-243. PubMed ID: 33612539
[TBL] [Abstract][Full Text] [Related]
18. Assessing the robustness of radiomics/deep learning approach in the identification of efficacy of anti-PD-1 treatment in advanced or metastatic non-small cell lung carcinoma patients.
Ren Q; Xiong F; Zhu P; Chang X; Wang G; He N; Jin Q
Front Oncol; 2022; 12():952749. PubMed ID: 35992867
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Pre-Treatment CT Radiomics and Clinical Factors for the Overall Survival of Advanced (IIIB-IV) Lung Adenocarcinoma Patients.
Hong D; Zhang L; Xu K; Wan X; Guo Y
Front Oncol; 2021; 11():628982. PubMed ID: 34123786
[TBL] [Abstract][Full Text] [Related]
20. A Radiomics-Clinical Model Predicts Overall Survival of Non-Small Cell Lung Cancer Patients Treated with Immunotherapy: A Multicenter Study.
Yolchuyeva S; Giacomazzi E; Tonneau M; Ebrahimpour L; Lamaze FC; Orain M; Coulombe F; Malo J; Belkaid W; Routy B; Joubert P; Manem VSK
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
